Newsletter | October 4, 2022

10.04.22 -- 3 Tips For Purifying His-Tagged Proteins

 
New Podcast Episode
Industry Insights
3 Tips For Purifying His-Tagged Proteins

Tags simplify purification and enable scientists to use standard protocols while also improving the yield, purity, and solubility of the protein of interest.

Effects Of The Ongoing Pandemic On Bupivacaine HCI Supply

Throughout the pandemic, painkiller and sedative demands have spiked. Drug manufacturers and CDMOs have become critical in efforts to stabilize the supply of bupivacaine HCl and other essential drugs.

Ensure High Quantity And Quality Of Isolated Bacterial Ribonucleic Acid (RNA)

In this scientific brief we evaluate the performance of the Pall Nucleic acid binding (NAB) Nanosep centrifugal device for nucleic acid isolation.

Pinpoint Manufacturing Steps That Require Tighter Control

With a complete picture of the parameters that control each step during manufacturing, chemists can monitor and control individual reactions to optimize the overall production process.

How Can You Ensure Successful Late-Phase Development And Launch Of Your Biologic Drug Product?

It is important to consider several factors in the overall development approach during the early phases in order to de-risk late-phase development.

The Development, Scale-Up, And Manufacturing Of Semi-Solid Dosage Forms

Topical products, whether prescription dermatological drugs or over-the-counter lotions, creams, or gels, present unique challenges in terms of development and manufacturing.

Global Biopharma Improves Product Purity And Reduces Costs With Biovia Discoverant

Following several mergers and acquisitions, a biopharmaceutical company had to manage an increasing amount of data from disparate online and offline sources. A solution allowed them to access data from various sources and to feed other systems with data quickly to support the company’s digital science and manufacturing informatics strategies.

Enabling Early Assessment Of Drug Targets To Maximize Clinical And Commercial Success

Comprehensive diligence around a target before starting a discovery program can make the difference between success and failure.

Antibody-Drug Conjugates: Next Generation Of Targeted Cancer Treatments

Manufacturing complex and highly potent ADC treatments presents unique challenges. Get an insider look at how these treatments make it from development to commercialization.

Most Popular News
Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.